Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, UTMD trades at $64.17 with a market cap of $203.78M and a P/E ratio of 19.03. UTMD moved +0.00% today. Year to date, UTMD is +11.41%; over the trailing twelve months it is +18.35%. Its 52-week range spans $51.26 to $71.81. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for UTMD shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $64.17 |
| Market Cap | $203.78M |
| P/E Ratio | 19.03 |
| EPS | $3.38 |
| Dividend Yield | 0.31% |
| 52-Week High | $71.81 |
| 52-Week Low | $51.26 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $37.53M |
| Net Income | $10.85M |
| Gross Margin | 57.94% |
UTMD analyst coverage data. Average price target: $0.00.